Organon & Co
XMUN:7XP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Organon & Co
XMUN:7XP
|
US |
|
Fortive Corp
NYSE:FTV
|
US |
|
E
|
Energy Absolute PCL
SET:EA
|
TH |
|
American Electric Power Company Inc
NASDAQ:AEP
|
US |
|
Lennar Corp
NYSE:LEN
|
US |
|
F
|
Figure Technology Solutions Inc
NASDAQ:FIGR
|
US |
|
A
|
Adtalem Global Education Inc
DUS:DVY
|
US |
|
Express Inc
OTC:EXPRQ
|
US |
|
Broadridge Financial Solutions Inc
NYSE:BR
|
US |
|
Xylem Inc
NYSE:XYL
|
US |
|
Public Service Enterprise Group Inc
NYSE:PEG
|
US |
|
Pultegroup Inc
NYSE:PHM
|
US |
|
Alliant Energy Corp
NASDAQ:LNT
|
US |
|
Linea Directa Aseguradora SA Compania de Seguros y Reaseguros
MAD:LDA
|
ES |
Wall St Price Targets
7XP Price Targets Summary
Organon & Co
According to Wall Street analysts, the average 1-year price target for 7XP is 9.37 EUR with a low forecast of 6.87 EUR and a high forecast of 12.51 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7XP's stock price target?
Price Target
9.37
EUR
According to Wall Street analysts, the average 1-year price target for 7XP is 9.37 EUR with a low forecast of 6.87 EUR and a high forecast of 12.51 EUR.
What is the Revenue forecast for Organon & Co?
Projected CAGR
0%
Over the last 7 years, the compound annual growth rate for Revenue has been -6%. The projected CAGR for the next 7 years is 0%.
What is the Operating Income forecast for Organon & Co?
Projected CAGR
4%
Over the last 7 years, the compound annual growth rate for Operating Income has been -10%. The projected CAGR for the next 7 years is 4%.
What is the Net Income forecast for Organon & Co?
Projected CAGR
26%
Over the last 7 years, the compound annual growth rate for Net Income has been -29%. The projected CAGR for the next 7 years is 26%.
